69 related articles for article (PubMed ID: 20198324)
21. Identifying Drug Targets of Oral Squamous Cell Carcinoma through a Systems Biology Method and Genome-Wide Microarray Data for Drug Discovery by Deep Learning and Drug Design Specifications.
Lin YC; Chen BS
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142321
[TBL] [Abstract][Full Text] [Related]
22. A γ-Secretase Inhibitor Attenuates Cell Cycle Progression and Invasion in Human Oral Squamous Cell Carcinoma: An In Vitro Study.
Pongjantarasatian S; Nowwarote N; Rotchanakitamnuai V; Srirodjanakul W; Saehun R; Janebodin K; Manokawinchoke J; Fournier BPJ; Osathanon T
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012128
[TBL] [Abstract][Full Text] [Related]
23. AL101, a gamma-secretase inhibitor, has potent antitumor activity against adenoid cystic carcinoma with activated NOTCH signaling.
Ferrarotto R; Mishra V; Herz E; Yaacov A; Solomon O; Rauch R; Mondshine A; Motin M; Leibovich-Rivkin T; Davis M; Kaye J; Weber CR; Shen L; Pearson AT; Rosenberg AJ; Chen X; Singh A; Aster JC; Agrawal N; Izumchenko E
Cell Death Dis; 2022 Aug; 13(8):678. PubMed ID: 35931701
[TBL] [Abstract][Full Text] [Related]
24. Shooting at Moving and Hidden Targets-Tumour Cell Plasticity and the Notch Signalling Pathway in Head and Neck Squamous Cell Carcinomas.
Kałafut J; Czerwonka A; Anameriç A; Przybyszewska-Podstawka A; Misiorek JO; Rivero-Müller A; Nees M
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944837
[TBL] [Abstract][Full Text] [Related]
25. Comprehending the crosstalk between Notch, Wnt and Hedgehog signaling pathways in oral squamous cell carcinoma - clinical implications.
Patni AP; Harishankar MK; Joseph JP; Sreeshma B; Jayaraj R; Devi A
Cell Oncol (Dordr); 2021 Jun; 44(3):473-494. PubMed ID: 33704672
[TBL] [Abstract][Full Text] [Related]
26. Development and Radiation Response Assessment in A Novel Syngeneic Mouse Model of Tongue Cancer: 2D Culture, 3D Organoids and Orthotopic Allografts.
Vincent-Chong VK; Seshadri M
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32131500
[TBL] [Abstract][Full Text] [Related]
27. Multifactorial Contribution of Notch Signaling in Head and Neck Squamous Cell Carcinoma.
Porcheri C; Meisel CT; Mitsiadis T
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30917608
[TBL] [Abstract][Full Text] [Related]
28. Notch1 serves as a prognostic factor and regulates metastasis via regulating EGFR expression in hypopharyngeal squamous cell carcinoma.
Tian J; Liu X; Liu X; Jing P; Sa N; Wang H; Xu W
Onco Targets Ther; 2018; 11():7395-7405. PubMed ID: 30425527
[TBL] [Abstract][Full Text] [Related]
29. Expression and oncogenic properties of membranous Notch1 in oral leukoplakia and oral squamous cell carcinoma.
Ding X; Zheng Y; Wang Z; Zhang W; Dong Y; Chen W; Li J; Chu W; Zhang W; Zhong Y; Mao L; Song X; Wu Y
Oncol Rep; 2018 Jun; 39(6):2584-2594. PubMed ID: 29620248
[TBL] [Abstract][Full Text] [Related]
30. FOXP3 expression is modulated by TGF‑β1/NOTCH1 pathway in human melanoma.
Skarmoutsou E; Bevelacqua V; D' Amico F; Russo A; Spandidos DA; Scalisi A; Malaponte G; Guarneri C
Int J Mol Med; 2018 Jul; 42(1):392-404. PubMed ID: 29620159
[TBL] [Abstract][Full Text] [Related]
31. The NOTCH Pathway in Head and Neck Squamous Cell Carcinoma.
Fukusumi T; Califano JA
J Dent Res; 2018 Jun; 97(6):645-653. PubMed ID: 29489439
[TBL] [Abstract][Full Text] [Related]
32. MicroRNAs as effective surrogate biomarkers for early diagnosis of oral cancer.
Cao M; Zheng L; Liu J; Dobleman T; Hu S; Go VLW; Gao G; Xiao GG
Clin Oral Investig; 2018 Mar; 22(2):571-581. PubMed ID: 29299731
[TBL] [Abstract][Full Text] [Related]
33. Interplay between Notch1 and Notch3 promotes EMT and tumor initiation in squamous cell carcinoma.
Natsuizaka M; Whelan KA; Kagawa S; Tanaka K; Giroux V; Chandramouleeswaran PM; Long A; Sahu V; Darling DS; Que J; Yang Y; Katz JP; Wileyto EP; Basu D; Kita Y; Natsugoe S; Naganuma S; Klein-Szanto AJ; Diehl JA; Bass AJ; Wong KK; Rustgi AK; Nakagawa H
Nat Commun; 2017 Nov; 8(1):1758. PubMed ID: 29170450
[TBL] [Abstract][Full Text] [Related]
34. The
Fukusumi T; Guo TW; Sakai A; Ando M; Ren S; Haft S; Liu C; Amornphimoltham P; Gutkind JS; Califano JA
Clin Cancer Res; 2018 Feb; 24(3):619-633. PubMed ID: 29146722
[No Abstract] [Full Text] [Related]
35. Notch as a tumour suppressor.
Nowell CS; Radtke F
Nat Rev Cancer; 2017 Mar; 17(3):145-159. PubMed ID: 28154375
[TBL] [Abstract][Full Text] [Related]
36. Notch pathway activation is essential for maintenance of stem-like cells in early tongue cancer.
Upadhyay P; Nair S; Kaur E; Aich J; Dani P; Sethunath V; Gardi N; Chandrani P; Godbole M; Sonawane K; Prasad R; Kannan S; Agarwal B; Kane S; Gupta S; Dutt S; Dutt A
Oncotarget; 2016 Aug; 7(31):50437-50449. PubMed ID: 27391340
[TBL] [Abstract][Full Text] [Related]
37. Deubiquitylating enzyme, USP9X, regulates proliferation of cells of head and neck cancer lines.
Nanayakkara DM; Nguyen MN; Wood SA
Cell Prolif; 2016 Aug; 49(4):494-502. PubMed ID: 27374971
[TBL] [Abstract][Full Text] [Related]
38. Does Notch play a tumor suppressor role across diverse squamous cell carcinomas?
Zhang M; Biswas S; Qin X; Gong W; Deng W; Yu H
Cancer Med; 2016 Aug; 5(8):2048-60. PubMed ID: 27228302
[TBL] [Abstract][Full Text] [Related]
39. Expression pattern of Notch intracellular domain (NICD) and Hes-1 in preneoplastic and neoplastic human oral squamous epithelium: their correlation with c-Myc, clinicopathological factors and prognosis in Oral cancer.
Gokulan R; Halagowder D
Med Oncol; 2014 Aug; 31(8):126. PubMed ID: 25037575
[TBL] [Abstract][Full Text] [Related]
40. Cellular senescence checkpoint function determines differential Notch1-dependent oncogenic and tumor-suppressor activities.
Kagawa S; Natsuizaka M; Whelan KA; Facompre N; Naganuma S; Ohashi S; Kinugasa H; Egloff AM; Basu D; Gimotty PA; Klein-Szanto AJ; Bass AJ; Wong KK; Diehl JA; Rustgi AK; Nakagawa H
Oncogene; 2015 Apr; 34(18):2347-59. PubMed ID: 24931169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
